Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
US12378254B2 · kind B2 · utility
0Cited by
54References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 2, 2023 |
| Grant date | Aug 5, 2025 |
| Priority date | — |
| Expiry date | Jun 2, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disubstituted octahydropyrrolo[3,4-c]pyrrole compounds are described, which are useful as orexin receptor modulators. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.